Status:
RECRUITING
Application of Multimodal Large Language Model in HFpEF
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Tianjin Medical University General Hospital
The First Hospital of Hebei Medical University
Conditions:
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
18-80 years
Brief Summary
This study will validate the effectiveness of a multimodal large language model to screen for heart failure with preserved ejection fraction (HFpEF), comparing it with the traditional clinical standar...
Detailed Description
Heart failure is a major complication of various heart diseases and is the leading lethal cause of cardiovascular death worldwide. Based on the left ventricular ejection fraction (LVEF), heart failure...
Eligibility Criteria
Inclusion
- Age 18-80 years, male or female;
- Cardiology inpatients with suspected heart failure with preserved ejection fraction (cardiac ultrasound suggestive of LVEF ≥50% with at least 1 of the following: 1, left ventricular hypertrophy and/or left atrial enlargement; and 2, abnormal diastolic cardiac function);
- Current or previous at least one symptom of heart failure, including dyspnea (including exertional dyspnea, nocturnal paroxysmal dyspnea, and telangiectasia), malaise, nausea, and bilateral lower extremity edema;
- Voluntary participation and signed informed consent.
Exclusion
- Acute heart failure or acute worsening of chronic heart failure;
- Severe coronary stenosis (≥75% stenosis) without revascularization;
- Patients who are unable to perform exercise stress echocardiography or have contraindications to the test;
- are participating in other clinical trials;
- Those with severe organic pathologies of the liver, kidney, or hematologic system or those with chronic diseases;
- Those who are unable to follow the trial procedures;
- Those who refuse to sign the informed consent.
Key Trial Info
Start Date :
December 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06486649
Start Date
December 20 2023
End Date
December 20 2024
Last Update
July 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking UniversityThird Hospital
Beijing, Beijing Municipality, China